Cargando…
Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study
OBJECTIVE: To examine associations between maternal use of cough medications containing dextromethorphan (DM) without guaifenesin (glyceryl guaiacolate (GG)) (‘DM alone’), GG without DM (‘GG alone’) or DM +GG and major birth defects in offspring. DESIGN: Population-based case–control study. SETTING:...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718348/ http://dx.doi.org/10.1136/bmjopen-2021-053604 |
_version_ | 1784624705340178432 |
---|---|
author | Cao, Yanyan Rhoads, Anthony Burns, Trudy Carnahan, Ryan M Conway, Kristin M Werler, Martha M Mitchell, Allen Romitti, Paul |
author_facet | Cao, Yanyan Rhoads, Anthony Burns, Trudy Carnahan, Ryan M Conway, Kristin M Werler, Martha M Mitchell, Allen Romitti, Paul |
author_sort | Cao, Yanyan |
collection | PubMed |
description | OBJECTIVE: To examine associations between maternal use of cough medications containing dextromethorphan (DM) without guaifenesin (glyceryl guaiacolate (GG)) (‘DM alone’), GG without DM (‘GG alone’) or DM +GG and major birth defects in offspring. DESIGN: Population-based case–control study. SETTING: The multisite, US National Birth Defects Prevention Study. PARTICIPANTS: Mothers of 1644 children with neural tube defects (NTDs), 15 110 with non-NTDs, and 10 671 control children without a birth defect diagnosis. MAIN OUTCOME MEASURES: ORs and 95% CIs. RESULTS: For NTD analysis, 1.7% of mothers of case children and 1.2% of mothers of control children reported using DM alone, 1.1% and 0.6% GG alone, and 0.4% and 0.2% DM +GG. Respective percentages for non-NTD analysis were 2.2% and 1.9% for DM alone, 1.7% and 1.6% for GG alone, and 0.5% and 0.4% for DM +GG. For all NTDs and subtypes, adjusted OR estimates for DM alone were near the null with 95% CIs that included 1.0. Estimates (95% CI) were 1.8 (1.0 to 3.3) for GG alone and 1.8 (0.6 to 4.8) for DM +GG with all NTDs and 2.2 (1.1 to 4.3) for GG alone with spina bifida. Of the 45 adjusted OR estimates for non-NTDs, 39 ranged from 0.5 to 1.6 with 95% CIs that included 1.0. Near twofold or higher estimates (95% CI) were observed for the remainder and included 1.9 (1.0 to 3.7) for hydrocephalus, 2.9 (1.3 to 6.5) for atrioventricular septal defect and 1.8 (1.1 to 3.0) for transverse limb deficiency with DM alone; 2.1 (1.1 to 4.0) for small intestinal atresia/stenosis and 2.1 (0.9 to 4.5) for omphalocele with GG alone; and 3.2 (1.5 to 6.9) for gastroschisis with DM +GG. CONCLUSIONS: Maternal use of medications containing DM alone, GG alone or DM +GG showed positive associations with a small number of birth defects. These observations, which should be interpreted with caution due to small proportions of exposed mothers, may represent true signals or chance findings and warrant evaluation in future studies. |
format | Online Article Text |
id | pubmed-8718348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87183482022-01-04 Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study Cao, Yanyan Rhoads, Anthony Burns, Trudy Carnahan, Ryan M Conway, Kristin M Werler, Martha M Mitchell, Allen Romitti, Paul BMJ Open Epidemiology OBJECTIVE: To examine associations between maternal use of cough medications containing dextromethorphan (DM) without guaifenesin (glyceryl guaiacolate (GG)) (‘DM alone’), GG without DM (‘GG alone’) or DM +GG and major birth defects in offspring. DESIGN: Population-based case–control study. SETTING: The multisite, US National Birth Defects Prevention Study. PARTICIPANTS: Mothers of 1644 children with neural tube defects (NTDs), 15 110 with non-NTDs, and 10 671 control children without a birth defect diagnosis. MAIN OUTCOME MEASURES: ORs and 95% CIs. RESULTS: For NTD analysis, 1.7% of mothers of case children and 1.2% of mothers of control children reported using DM alone, 1.1% and 0.6% GG alone, and 0.4% and 0.2% DM +GG. Respective percentages for non-NTD analysis were 2.2% and 1.9% for DM alone, 1.7% and 1.6% for GG alone, and 0.5% and 0.4% for DM +GG. For all NTDs and subtypes, adjusted OR estimates for DM alone were near the null with 95% CIs that included 1.0. Estimates (95% CI) were 1.8 (1.0 to 3.3) for GG alone and 1.8 (0.6 to 4.8) for DM +GG with all NTDs and 2.2 (1.1 to 4.3) for GG alone with spina bifida. Of the 45 adjusted OR estimates for non-NTDs, 39 ranged from 0.5 to 1.6 with 95% CIs that included 1.0. Near twofold or higher estimates (95% CI) were observed for the remainder and included 1.9 (1.0 to 3.7) for hydrocephalus, 2.9 (1.3 to 6.5) for atrioventricular septal defect and 1.8 (1.1 to 3.0) for transverse limb deficiency with DM alone; 2.1 (1.1 to 4.0) for small intestinal atresia/stenosis and 2.1 (0.9 to 4.5) for omphalocele with GG alone; and 3.2 (1.5 to 6.9) for gastroschisis with DM +GG. CONCLUSIONS: Maternal use of medications containing DM alone, GG alone or DM +GG showed positive associations with a small number of birth defects. These observations, which should be interpreted with caution due to small proportions of exposed mothers, may represent true signals or chance findings and warrant evaluation in future studies. BMJ Publishing Group 2021-12-30 /pmc/articles/PMC8718348/ http://dx.doi.org/10.1136/bmjopen-2021-053604 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Cao, Yanyan Rhoads, Anthony Burns, Trudy Carnahan, Ryan M Conway, Kristin M Werler, Martha M Mitchell, Allen Romitti, Paul Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study |
title | Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study |
title_full | Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study |
title_fullStr | Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study |
title_full_unstemmed | Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study |
title_short | Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study |
title_sort | maternal use of cough medications during early pregnancy and selected birth defects: a us multisite, case–control study |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718348/ http://dx.doi.org/10.1136/bmjopen-2021-053604 |
work_keys_str_mv | AT caoyanyan maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT rhoadsanthony maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT burnstrudy maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT carnahanryanm maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT conwaykristinm maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT werlermartham maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT mitchellallen maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy AT romittipaul maternaluseofcoughmedicationsduringearlypregnancyandselectedbirthdefectsausmultisitecasecontrolstudy |